Latest filings (excl ownership)
8-K
Pulmonx Reports First Quarter 2024 Financial Results
1 May 24
ARS
2023 FY
Annual report to shareholders
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
8-K
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
2 Apr 24
S-8
Registration of securities for employees
15 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
21 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Pulmonx Reports Record Third Quarter 2023 Financial Results
30 Oct 23
8-K
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
10 Oct 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
8-K
Pulmonx Reports Second Quarter 2023 Financial Results
2 Aug 23
SD
Conflict minerals disclosure
26 May 23
8-K
Submission of Matters to a Vote of Security Holders
18 May 23
S-8
Registration of securities for employees
9 May 23
10-Q
2023 Q1
Quarterly report
8 May 23
8-K
Pulmonx Reports First Quarter 2023 Financial Results
2 May 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
DEFA14A
Additional proxy soliciting materials
4 Apr 23
DEF 14A
Definitive proxy
4 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
22 Feb 23
EFFECT
Notice of effectiveness
16 Nov 22
S-3/A
Shelf registration (amended)
14 Nov 22
CORRESP
Correspondence with SEC
10 Nov 22
UPLOAD
Letter from SEC
9 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
S-3
Shelf registration
3 Nov 22
8-K
Pulmonx Reports Third Quarter 2022 Financial Results
3 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
8-K
Pulmonx Reports Second Quarter 2022 Financial Results
2 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
27 May 22
S-8
Registration of securities for employees
10 May 22
10-Q
2022 Q1
Quarterly report
9 May 22
8-K
Pulmonx Reports First Quarter 2022 Financial Results
3 May 22
DEFA14A
Additional proxy soliciting materials
15 Apr 22
DEF 14A
Definitive proxy
15 Apr 22
10-K
2021 FY
Annual report
1 Mar 22
Latest ownership filings
4
Geoffrey Beran Rose
24 Apr 24
144
Notice of proposed sale of securities
22 Apr 24
3
Mehul Joshi
9 Apr 24
4
Geoffrey Beran Rose
26 Mar 24
144
Notice of proposed sale of securities
22 Mar 24
4
Steven S. Williamson
19 Mar 24
3
Steven S. Williamson
19 Mar 24
SC 13G/A
FMR LLC
11 Mar 24
4/A
Geoffrey Beran Rose
7 Mar 24
4/A
John McKune
7 Mar 24
4/A
David Aaron Lehman
7 Mar 24
4
Geoffrey Beran Rose
5 Mar 24
4
John McKune
5 Mar 24
4
David Aaron Lehman
5 Mar 24
4
Glendon E. French III
5 Mar 24
SC 13G
Point72 Asset Management, L.P.
29 Feb 24
4
Geoffrey Beran Rose
26 Feb 24
144
Notice of proposed sale of securities
22 Feb 24
4
Glendon E. French III
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Champlain Investment Partners, LLC
13 Feb 24
SC 13G/A
Flynn James E
12 Feb 24
SC 13G/A
PRIMECAP MANAGEMENT CO/CA/
12 Feb 24
SC 13G/A
MORGAN STANLEY
9 Feb 24
SC 13G
FMR LLC
9 Feb 24
144
Notice of proposed sale of securities
31 Jan 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4
Geoffrey Beran Rose
24 Jan 24
4
Glendon E. French III
22 Jan 24
144
Notice of proposed sale of securities
22 Jan 24
144
Notice of proposed sale of securities
18 Jan 24
4
Geoffrey Beran Rose
27 Dec 23
4
Glendon E. French III
22 Dec 23
144
Notice of proposed sale of securities
22 Dec 23
144
Notice of proposed sale of securities
21 Dec 23
4
Geoffrey Beran Rose
5 Dec 23
4
John McKune
5 Dec 23
4
David Aaron Lehman
5 Dec 23